Research Faculty


Jianfeng Lu, M.D., Ph.D.
Associate Research Scientist
Phone: 734-647-7949


Campus address:
University of Michigan Comprehensive Cancer Center
Room 3111
1500 E Medical Center Drive/SPC 5934
Ann Arbor, MI 48109

Research Interests

Development of targeted new anticancer drugs and their molecular mechanism of action

Education and Training

1984 M.D. & B.M., Clinical Medicine, Henan Science and Technology University Medical College, Henan Province, China
1990 M.S., Pancreas and Liver Transplantation, Portal Hypertension, Henan Medical University, Zhengzhou, P.R. China
2001 Ph.D., Experimental Surgery, Peking University, Beijing, P.R. China. Thesis: Experimental study on immunotherapy of hepatocarcinoma by using Mage (a cancer-testis antigen) antigen.
2004-2010 Postdoc Fellow, University of Michigan Cancer Center, investigating the apoptosis mechanism of cancer cells treated with Smac mimetics developed in Shaomeng Wang's lab.

Selected Publications (2008-present)

  1. Sun H, Nikolovska-Coleska Z, Yang CY, Qian D, Lu J, Qiu S, Bai L, Peng Y, Cai Q, Wang S. Design of small-molecule peptidic and nonpeptidic Smac mimetics. Acc Chem Res, 2008 Oct; 41(10):1264-1277. (PMID 18937395)  PMC 2676167.

  2. Lu J, Bai L, Sun H, Nikolovska-Coleska Z, McEachern D, Qiu S, Miller RS, Yi H, Shangary S, Sun Y, Meagher JL, Stuckey JA, Wang S.  SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP. Cancer Res, 2008 Nov 15; 68(22):9384-9393. (PMID 19010913) PMC 2784911.

  3. Sun H, Stuckey JA, Nikolovska-Coleska Z, Qin D, Meagher JL, Qiu S, Lu J, Yang CY, Saito NG, Wang S. Structure-based design, synthesis, evaluation, and crystallographic studies of conformationally constrained Smac mimetics as inhibitors of the X-linked inhibitor of apoptosis protein (XIAP). J Med Chem, 2008 Nov 27; 51(22):7169-7180. (PMID 18954041) PMC 2688463.

  4. Peng Y, Sun H, Nikolovska-Coleska Z, Qiu S, Yang CY, Lu J, Cai Q, Yi H, Kang S, Yang D, Wang S. Potent, orally bioavailable diazabicyclic small-molecule mimetics of second mitochondria-derived activator of caspases. J Med Chem, 2008 Dec 25; 51(24):8158-8162. (PMID 19049347)  PMC 2679375.

  5. Sun H, Liu L, Lu J, Qiu S, Yang CY, Yi H, Wang S.  Cyclopeptide Smac mimetics as antagonists of IAP proteins. Bioorg Med Chem Lett, 2010 Apr 3. (PMID 20456952). Sun H, Lu J, Liu L, Yi H, Qiu S, Yang CY, Deschamps JR, Wang S.  Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins. J Med Chem, 2010 Sep 9; 53(17):6361-6367. (PMID 20684551)  PMC 2936695.

  6. Cai Q, Sun H, Peng Y, Lu J, Nikolovska-Coleska Z, McEachern D, Liu L, Qiu S, Yang CY, Miller R, Yi H, Zhang T, Sun D, Kang S, Guo M, Leopold L, Yang D, Wang S.  A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. J Med Chem, 2011 Apr 28; 54(8):2714-2726. (PMID 21443232)  PMC 3520070.

  7. Lu J, McEachern D, Sun H, Bai L, Peng Y, Qiu S, Miller R, Liao J, Yi H, Liu M, Bellail A, Hao C, Sun SY, Ting AT, Wang S.  Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment. Mol Cancer Ther, 2011 May; 10(5):902-914. (PMID 21372226)  PMC 3091962.

  8. Sun H, Liu L, Lu J, Bai L, Li X, Nikolovska-Coleska Z, McEachern D, Yang CY, Qiu S, Yi H, Sun D, Wang S. Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity. J Med Chem, 2011 May 12; 54(9):3306-3318. (PMID 21462933)  PMC 3108148.

  9. Peng Y, Sun H, Lu J, Liu L, Cai Q, Shen R, Yang CY, Yi H, Wang S.  Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents. J Med Chem, 2012 Jan 12; 55(1):106-114. (PMID 22148838).

  10. Bai L, McEachern D, Yang CY, Lu J, Sun H, Wang S.  LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFalpha expression and receptor tyrosine kinase signaling. Cancer Res, 2012 Mar 1; 72(5):1229-1238. (PMID 22241084)  PMC 3294058.

  11. Wang S, Bai L, Lu J, Liu L, Yang CY, Sun H.  Targeting inhibitors of apoptosis proteins (IAPs) for new breast cancer therapeutics. J Mammary Gland Biol Neoplasia, 2012 Dec; 17(3-4):217-228. (PMID 23054134)  PMC 3534930.

  12. Zhao Y, Liu L, Sun W, Lu J, McEachern D, Li X, Yu S, Bernard D, Ochsenbein P, Ferey V, Carry JC, Deschamps JR, Sun D, Wang S.  Diastereomeric spirooxindoles as highly potent and efficacious MDM2 inhibitors. J Am Chem Soc, 2013 May 15; 135(19):7223-7234. (PMID 23641733).

  13. Sheng R, Sun H, Liu L, Lu J, McEachern D, Wang G, Wen J, Min P, Du Z, Lu H, Kang S, Guo M, Yang D, Wang S.  A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice. J Med Chem, 2013 May 23; 56(10):3969-3979. (PMID 23651223).

Updated 7/16